Bristol Promises 12-Month Moratorium On DTC For Newly Launched Products
This article was originally published in The Pink Sheet Daily
Executive Summary
The company will focus on educating medical professionals during the first year a drug is on the market under a new DTC communication code. When products are advertised to consumers, Bristol will target "appropriate" populations, the firm says.
You may also be interested in...
Pfizer Guidelines Call For Physician Education For Six Months Prior To DTC
Stay on DTC is more specific than PhRMA’s DTC guiding principles, which require an “appropriate amount of time” be spent on physician education prior to campaign launch.
Pfizer Guidelines Call For Physician Education For Six Months Prior To DTC
Stay on DTC is more specific than PhRMA’s DTC guiding principles, which require an “appropriate amount of time” be spent on physician education prior to campaign launch.
Sen. Frist's Diagnosis On DTC: GAO Report, Two-Year Moratorium For New Drugs
Majority Leader Frist requests Government Accountability Office examine FDA's oversight of direct-to-consumer ads and their impact on drug usage and costs. The senator also requests drug companies voluntarily restrict DTC ads during the first two years a product is on the market.